Dr. Andrea Fava, MD

Dr. Fava practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Fava's NPI, 1518384098, was assigned on March 24, 2014. Dr. Fava holds Maryland license D0088580.

Dr. Fava's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Fava's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Fava is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Fava to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fava practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Fava's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Fava is licensed in Maryland.

CMS data shows 136 Medicare services from Dr. Fava across 4 procedure codes in 2024, for 66 Medicare patients. Medicare paid $8,230 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Fava in 2024. The largest group is under 65, with 31 patients. 75% of them have high blood pressure, and 67% have arthritis. 35% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fava's median patient age at 49, with 86% women.

In 2024, Dr. Fava wrote 249 Medicare Part D claims for 38 patients. 72% of them were for generic drugs. CMS names the drug for 164 of them, across 4 drugs with 11 or more claims each, at $257,058 in total drug cost. In 2023, CMS named 163 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Fava for performance year 2024, reported as part of a group. CMS lists Dr. Fava as offering telehealth.

Dmand AI links 40 papers to Dr. Fava, published from 2012 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Lupus Erythematosus, Systemic, Lupus Nephritis and Kidney. Dr. Fava has published most often in Arthritis Care Res (Hoboken). Dr. Fava's most frequent co-authors are Michelle A. Petri, MD, Deepak Angara Rao, MD, PhD and Francesco Boin, MD.

CMS Open Payments shows 51 general payments to Dr. Fava from 14 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $14,147.